This is a fundamental injectable versus oral peptide distinction that applies broadly across peptide therapeutics
Some providers extend the time at each dose level to two months instead of one, especially when transitioning to higher doses
At the same time, chronic inflammation is also an important driving factor for the progress of kidney disease
Berberine demonstrates DPP-4 inhibitory activity in cell culture and animal studies, potentially extending the half-life of naturally produced GLP-1
10.1155/2013/172494 42 PinnellA
10.1016/j.scitotenv.2020.144781 [DOI] [PubMed] [Google Scholar] Abrehame S, Manoj VR, Hailu M, Chen Y-Y, Lin Y-C, Chen Y-P (2023) Aflatoxins: Source, Detection, Clinical Features and Prevention